Ireland· IE-PA-PA23180/017/001
Dulcolax Pico Liquid 5 mg/5 ml oral solution
A sodium picosulfate product containing sodium picosulfate, registered in Ireland by Opella Healthcare France SAS T/A Sanofi. The same ATC class is registered in 12 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Sodium picosulfate is registered in 12 of 19 countries.
Countries holding a registration under ATC A06AB08 (sodium picosulfate), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Sodium picosulfate · ATC A06AB08
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Japan
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
HPRA (Ireland)- Active substance
- Sodium picosulfate
- Manufacturer
- Opella Healthcare France SAS T/A Sanofi
- Country
- Ireland (IE)
- ATC code
- A06AB08
- ATC class
- Sodium picosulfate
- Defined daily dose
- 5 mg, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA23180/017/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
516 interactions on record for sodium picosulfate.
Graded by severity as the source publishes them — 37 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sodium picosulfate · interactions on record
516 records
- 37 severe
- 475 moderate
- 4 minor
Most severe, free to view
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- QuinidineC01BA01severe
- ProcainamideC01BA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Sodium picosulfate in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaGALLAXGALMED a.s., Ostrava
- United KingdomCitraFleet oral powder 15.08g sachetsRecordati Pharmaceuticals Ltd
- GermanyDulcolax Np PerlenA. Nattermann & Cie. Gmbh
- FinlandAgiopicMadaus GmbH
- BelgiumDulcolax Picosulphate 2.5 mgOpella Healthcare Belgium
- SwedenCilaxoral 7,5 mg/ml Orala droppar, lösningNordic Drugs AB
- NorwayLaxoberalOpella Healthcare France SAS
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Agaffin, Guttalax
- Belgium · Dulcolax Picosulphate, Fructines
- Bulgaria · Глицеракс Пико, Дулколакс Пико
- Czechia · Gallax, Guttalax
- Germany · Dulcolax Np Perlen, Dulcolax Np Tropfen
- Denmark · Actilax, Laxoberal
- Estonia · Guttalax, Regulax
- Spain · Dulcolax Picosulfato, Evacuol
- Finland · Laxoberon, Picorion
- France · Fructines
- United Kingdom (Northern Ireland) · Dulcolax Adult Pico Liquid, Dulcolax Adult Pico Perles
- Greece · Dulcoflex
- Hungary · Dulcolax, Stadalax
- Iceland · Laxoberal
- Italy · Euchessina C.M., Gocce Lassative Aicardi
- Lithuania · Regulax
- Luxembourg · Laxoberon
- Latvia · Guttalax, Regulax
- Malta · Dulcolax Pico Liquid
- Norway · Laxoberal
- Poland · Pikopil
- Portugal · Dulcolax Gotas, Enterex
- Romania · Dulcopic
- Sweden · Cilaxoral, Laxoberal
- Slovakia · Guttalax, Laxygal
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/47a69ec0-c5da-4336-99a7-4d3df92793b9 GET /v1/drugs/47a69ec0-c5da-4336-99a7-4d3df92793b9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oral solution",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"A06AB",
"A06AB08"
],
"strength": null,
"pa_number": "PA23180/017/001",
"substances": [
"Sodium picosulfate"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "31/08/1975",
"dispensing_status": "Product not subject to medical prescription",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about sodium picosulfate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.